Tianjin Eleli Technology Development
Retatrutide
Finnrick tested 6 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from Tianjin Eleli Technology Development between 26 Jan 2026 and 25 Mar 2026. Test scores average below 4 or some scores below 3, and at least 6 tests, warrant a confident Finnrick Rating of E (Bad).
Finnrick Rating™
Tianjin Eleli Technology Development
Retatrutide
Tested 6 Samples
Last test 25 Mar 2026
Take Action
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Retatrutide tests from top-rated vendors:
All Retatrutide tests from Tianjin Eleli Technology Development
Samples are tested in commercial labs
Tests Count
6
Scores
AVGMINMAX
Last
25 Mar 2026
First
26 Jan 2026
| Quantity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 25 Mar 2026 | View | 20mg | 20.6mg | +3.0% | 99.90% | (no batch ID) | No Label / Gold Crimp / Black Cap | Lab G | Public | |
| 3 Mar 2026 | View | 30mg | ⚠️ Sample does not contain Retatrutide | 12/2025 | No Label / Silver Crimp / Blue Cap | Lab E | Public | |||
| 3 Mar 2026 | View | 10mg | 10.2mg | +2.0% | 99.67% | (no batch ID) | No Label / Silver Crimp / Yellow Cap | Lab E | Public | |
| 10 Feb 2026 | View | 20mg | 21.9mg | +9.5% | 99.80% | (no batch ID) | No Label / Copper Crimp / Clear Cap | Lab G | Public | |
| 4 Feb 2026 | View | 10mg | 9mg | -10.0% | 98.60% | 10 | No Label / Silver Crimp / Orange Cap | Lab G | Public | |
| 26 Jan 2026 | View | 15mg | 15.2mg | +1.3% | 99.80% | (no batch ID) | White Label / Silver Crimp / Orange Cap | Lab E | Public | |